Literature DB >> 17927616

Spontaneous clearance of childhood hepatitis C virus infection.

L T F Yeung1, T To, S M King, E A Roberts.   

Abstract

To describe the spontaneous clearance rate of childhood hepatitis C virus (HCV) infection, to determine whether route of transmission affects the clearance rate and to identify other predictors of clearance. Children with chronic hepatitis C were identified between 1990 and 2001. The rate of spontaneous clearance (defined as >or=2 positive anti-HCV antibody test but negative HCV RNA) was calculated using survival analysis. Univariate and multivariate predictor variables [route of transmission, age at infection, age at last follow-up, alanine aminotransferase (ALT) and gender] for clearance were evaluated. Of 157 patients, 28% of children cleared infection (34 transfusional and 10 nontransfusional cases). The 123 transfusional cases were older at time of infection and at follow-up, compared with the 34 nontransfusional cases. Younger age at follow-up (p < 0.0001) and normal ALT levels (p < 0.0001) favoured clearance. Among cases of neonatal infection, 25% demonstrated spontaneous clearance by 7.3 years. The rate of spontaneous clearance of childhood HCV infection was comparable between transfusional and nontransfusional cases. If clearance occurs, it tends to occur early in infection, at a younger age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17927616     DOI: 10.1111/j.1365-2893.2007.00873.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  36 in total

1.  Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.

Authors:  S M Gadalla; L R Preiss; M E Eyster; J J Goedert
Journal:  J Viral Hepat       Date:  2011-03       Impact factor: 3.728

2.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

3.  Vertical transmission of the hepatitis C virus: Current knowledge and issues.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

Review 4.  Hepatitis B and C.

Authors:  Wikrom Karnsakul; Kathleen B Schwarz
Journal:  Pediatr Clin North Am       Date:  2017-06       Impact factor: 3.278

5.  Cost-effectiveness of screening for hepatitis C in Canada.

Authors:  William W L Wong; Hong-Anh Tu; Jordan J Feld; Tom Wong; Murray Krahn
Journal:  CMAJ       Date:  2015-01-12       Impact factor: 8.262

6.  Vertical transmission of hepatitis C virus in low to middle socio-economic pregnant population of Karachi.

Authors:  Sina Aziz; Nazli Hossain; Saadiya Aziz Karim; Jamila Rajper; Nargis Soomro; Wajeeha Noorulain; Rana Qamar; Rafiq Khanani
Journal:  Hepatol Int       Date:  2010-12-31       Impact factor: 6.047

Review 7.  Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.

Authors:  Pankaj Puri; Vivek A Saraswat; Radha K Dhiman; Anil C Anand; Subrat K Acharya; Shivaram P Singh; Yogesh K Chawla; Deepak N Amarapurkar; Ajay Kumar; Anil Arora; Vinod K Dixit; Abraham Koshy; Ajit Sood; Ajay Duseja; Dharmesh Kapoor; Kaushal Madan; Anshu Srivastava; Ashish Kumar; Manav Wadhawan; Amit Goel; Abhai Verma; Gaurav Pandey; Rohan Malik; Swastik Agrawal
Journal:  J Clin Exp Hepatol       Date:  2016-07-02

8.  Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.

Authors:  Alexander J Millman; Noele P Nelson; Claudia Vellozzi
Journal:  Curr Epidemiol Rep       Date:  2017-04-20

9.  Acute hepatitis C virus infection in a nurse trainee following a needlestick injury.

Authors:  Renzo Scaggiante; Liliana Chemello; Roberto Rinaldi; Giovanni Battista Bartolucci; Andrea Trevisan
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 10.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Shiv K Sarin; Radha K Dhiman; Rakesh Aggarwal; Shivaram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoor; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Samir Shah; Praveen K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.